sorry to back track on an older thread, but just wanted to see what people thought of the section of the recent TB syringe announcement (as quoted by sbvb back on 02.09.10) which refered to the "five-year expiry date... should help to finalize discussions with a number of interested U.S. healthcare distributors in the near future", with this five year testing due to be finished in September. This means we will have the confirmation of these results in the next 2-3 weeks, and hopefully some subsequent distributor deals soon after - may even be in October, assuming this is the final piece of the puzzle required to seal the deals. Wonder if there will be some dollars included in the announcement when it comes? So could be a couple of relatively big announcements coming up over the next few weeks.
Also, I assume the 5 year shelf life is designed so that once the relevant party purchases the syringes they have up to 5 years in which to use them, rather than (as per Sonpa's post) it be to cover the possibility that they will sit on Unilife's shelves before being sold.
- Forums
- ASX - By Stock
- UNS
- another piece of the puzzle
another piece of the puzzle, page-28
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add UNS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online